Works by Kaifeng Qiu

Results: 10

Toxicity profile characteristics of novel androgen-deprivation therapy agents in patients with prostate cancer: a meta-analysis.

Published in:

2018

By:

Jianhong Zhu;
Rifang Liao;
Chen Su;
Dan Liang;
Junyan Wu;
Kaifeng Qiu;
Jianfang Li;
Zhu, Jianhong;
Liao, Rifang;
Su, Chen;
Liang, Dan;
Wu, Junyan;
Qiu, Kaifeng;
Li, Jianfang

Publication type:

journal article

Ileus in patients treated with immune checkpoint inhibitors: A retrospective, pharmacovigilance study using Food and Drug Administration Adverse Event Reporting System database.

Published in:

Pharmacoepidemiology & Drug Safety, 2022, v. 31, n. 11, p. 1199, doi. 10.1002/pds.5493

By:

Gao, Siyuan;
He, Zhichao;
Zhu, Jianhong;
Liang, Dan;
Zhao, Wenxia;
Yang, Shan;
Jiang, Wei;
Qiu, Kaifeng;
Yu, Xiaoxia;
Wu, Junyan

Publication type:

Article

Double-negative feedback loop between long non-coding RNA TUG1 and miR-145 promotes epithelial to mesenchymal transition and radioresistance in human bladder cancer cells.

Published in:

FEBS Letters, 2015, v. 589, n. 20PartB, p. 3175, doi. 10.1016/j.febslet.2015.08.020

By:

Tan, Jiemei;
Qiu, Kaifeng;
Li, Mingyi;
Liang, Ying

Publication type:

Article

A pharmacovigilance analysis of FDA adverse event reporting system events for romosozumab.

Published in:

Expert Opinion on Drug Safety, 2023, v. 22, n. 4, p. 339, doi. 10.1080/14740338.2023.2130891

By:

Chen, Zepeng;
Li, Ming;
Li, Shuzhen;
Li, Yuxi;
Wu, Junyan;
Qiu, Kaifeng;
Yu, Xiaoxia;
Huang, Lin;
Chen, Guanghui

Publication type:

Article

Risk of adverse events in lymphoma patients treated with brentuximab vedotin: a systematic review and meta-analysis.

Published in:

Expert Opinion on Drug Safety, 2020, v. 19, n. 5, p. 617, doi. 10.1080/14740338.2020.1718103

By:

Gao, Siyuan;
Zhang, Mei;
Wu, Kaishan;
Zhu, Jianhong;
He, Zhichao;
Li, Jianfang;
Chen, Chuxiong;
Qiu, Kaifeng;
Yu, Xiaoxia;
Wu, Junyan

Publication type:

Article

Risk of fatigue in cancer patients receiving anti-EGFR monoclonal antibodies: results from a systematic review and meta-analysis of randomized controlled trial.

Published in:

International Journal of Clinical Oncology, 2018, v. 23, n. 2, p. 389, doi. 10.1007/s10147-017-1218-7

By:

Zhu, Jianhong;
Zhao, Wenxia;
Liang, Dan;
Li, Guocheng;
Qiu, Kaifeng;
Wu, Junyan;
Li, Jianfang

Publication type:

Article

Insulin-like growth factor-1 activates PI3K/Akt signalling to protect human retinal pigment epithelial cells from amiodarone-induced oxidative injury.

Published in:

2018

By:

Liao, Rifang;
Yan, Fengxia;
Zeng, Zhuanping;
Wang, Haitao;
Qiu, Kaifeng;
Xu, Jinying;
Zheng, Wenhua

Publication type:

journal article

SGLT-2 inhibitors and euglycemic diabetic ketoacidosis/diabetic ketoacidosis in FAERS: a pharmacovigilance assessment.

Published in:

Acta Diabetologica, 2023, v. 60, n. 3, p. 401, doi. 10.1007/s00592-022-02015-6

By:

He, Zhichao;
Lam, Kakei;
Zhao, Wenxia;
Yang, Shan;
Li, Yu;
Mo, Jiayao;
Gao, Siyuan;
Liang, Dan;
Qiu, Kaifeng;
Huang, Min;
Wu, Junyan

Publication type:

Article

Meta-analysis of randomized controlled trials for the incidence and risk of fatal adverse events in cancer patients treated with ipilimumab.

Published in:

Expert Opinion on Drug Safety, 2017, v. 16, n. 4, p. 423, doi. 10.1080/14740338.2017.1297420

By:

Zhu, Jianhong;
Wu, Junyan;
Li, Guocheng;
Li, Jianfang;
Lin, Yin;
He, Zhichao;
Su, Chen;
Zhao, Wenxia;
Wu, Qianqian;
Chen, Zepeng;
Qiu, Kaifeng

Publication type:

Article

Significance of Tumor-Infiltrating Lymphocytes and the Expression of Topoisomerase IIα in the Prediction of the Clinical Outcome of Patients with Triple-Negative Breast Cancer after Taxane-Anthracycline-Based Neoadjuvant Chemotherapy.

Published in:

Chemotherapy (0009-3157), 2017, v. 62, n. 4, p. 246, doi. 10.1159/000470900

By:

Rao, Nanyan;
Qiu, Jiayin;
Wu, Jiannan;
Zeng, Hong;
Su, Fengxi;
Qiu, Kaifeng;
Wu, Junyan;
Yao, Herui

Publication type:

Article